Hypoalbuminemia in renal failure: Pathogenesis and therapeutic considerations

Kidney and Blood Pressure Research

Volumn 28, Issue 5-6, 2006, Pages 307-310

  Haller, C ^a  

^a Hegau Bodensee Klinikum   (Germany)

Author keywords

Albumin; Dialysis; Inflammation; Malnutrition

Indexed keywords

ALBUMIN; HUMAN SERUM ALBUMIN;

ANAPHYLAXIS; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CORRELATION ANALYSIS; CRITICAL ILLNESS; DIALYSIS; EDEMA; EXTRAVASCULAR FLUID; FLUID TRANSPORT; HOMEOSTASIS; HUMAN; HYPOALBUMINEMIA; INFLAMMATION; INTENSIVE CARE UNIT; KIDNEY FAILURE; MALNUTRITION; MORTALITY; NONHUMAN; ONCOTIC PRESSURE; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; ULTRAFILTRATION;

ALBUMINS; HUMANS; HYPOALBUMINEMIA; KIDNEY FAILURE, CHRONIC;

EID: 33644983006     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090185     Document Type: Article

References (26)

1. Alderson P, Bunn F, Lefebvre C, Li LLW, Roberts I, Schierhout G: Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev 2004;18:CD001208.
2. Bologa RM, Levine DM, Parker TS, Cheigh JS, Serur D, Stenzel KH, Rubin AL: Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 1998;32:107-114.
3. Capelli JP, Kushner H, Camiscoli TC, Chen SM, Tores MA: Effect of intradialytic parenteral nutrition on mortality rates in end-stage renal disease care. Am J Kidney Dis 1994;23:808-816.
4. Combe C, McCullough KP, Asano Y, Ginsberg N, Maroni BJ, Pifer TB: Kidney disease outcomes quality initiative (K/DOQI) and dialysis outcomes and practice patterns study (DOPPS): nutrition guidelines, indicators, and practices. Am J Kidney Dis 2004;44:39-46.
5. Danielski M, Ikizler TA, McMonagle E, Kane JC, Pupim L, Morrow J, Himmelfarb J: Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy. Am J Kidney Dis 2003;42:286-294.
6. Don BR, Kaysen G: Serum albumin: relationship to inflammation and nutrition. Semin Dial 2004;17:432-437.
7. Eckhardt RD, Lewis JH, Murphy TL, Batchelor WH, Davidson CS: Chemical, clinical, and immunological studies on the products of human plasma fractionation. XXXIV. Comparative studies on the nutritive value of orally and intravenously administered human serum albumin in man. J Clin Invest 1947:119-134.
8. Fujihara CK, Limongi DM, DeOliveira HC, Zatz R: Absence of focal glomerulosclerosis in aging analbuminemic rats. Am J Physiol 1992;262: R947-R954.
9. Fujihara CK, Limongi DM, Falzone R, Graudenz MS, Zatz R: Pathogenesis of glomerular sclerosis in subtotally nephrectomized analbuminemic rats. Am J Physiol 1991;261:F256-F264.
10. Herrmann FR, Safran C, Levkoff SE, Minaker KL: Serum albumin level on admission as a predictor of death, length of stay, and readmission. Arch Intern Med 1992;152:125-130.
11. Honkanen E, Gronhagen-Riska C, Teppo AM, Maury CP, Meri S: Acute-phase proteins during hemodialysis: correlation with serum interleukin-1 beta levels and different dialysis membranes. Nephron 1991;57:283-287.
12. The SAFE Study Investigators: A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004;350:2247-2256.
13. Kaizu Y, Kimura M, Yoneyama T, Miyaji K, Hibi I, Kumagai H: Interleukin-6 may mediate malnutrition in chronic hemodialysis patients. Am J Kidney Dis 1998;31:93-100.
14. Kaplan AA, Halley SE, Lapkin RA, Graeber CW: Dialysate protein losses with bleach processed polysulphone dialyzers. Kidney Int 1995;47:573-578.
15. Kaysen GA: Biological basis of hypoalbuminemia in ESRD. J Am Soc Nephrol 1998;9:2368-2376.
16. Kaysen GA, Rathore V, Shearer GC, Depner TA: Mechanisms of hypoalbuminemia in hemodialysis patients. Kidney Int 1995;48:510-516.
17. Kaysen GA, Schoenfeld PY: Albumin homeostasis in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int 1984;25:107-114.
18. Kirsch R, Frith L, Black E, Hoffenberg R: Regulation of albumin synthesis and catabolism by alteration of dietary protein. Nature 1968;217:578-579.
19. Lowrie EG, Lew NL: Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990;15:458-482.
20. Memoli B, Libetta C, Rampino T, DeSimone W, Meccariello S, Stangherlin P, Canton AD, Andreucci VE: Interleukin-6 production of uraemic haemodialysed patients: effects of different membranes. Nephrol Dial Transplant 1991;6:96-98.
21. Minamiyama Y, Takemura S, Inoue M: Albumin is an important vascular tonus regulator as a reservoir of nitric oxide. Biophys Res Commun 1996;225:112-115.
22. Moshage HJ, Janssen JAM, Franssen JH, Hafkenscheid JCM, Yap SH: Study of the molecular mechanisms of decreased liver synthesis of albumin in inflammation. J Clin Invest 1987;79:1635-1641.
23. Cochrane Injuries Group Albumin Reviewers: Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ 1998;317:235-240.
24. Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del-Arbol L, et al: Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999;341:403-409.
25. Stafford CT, Lobel SA, Fruge BC, Moffitt JE, Hoff RG, Fadel HE: Anaphylaxis to human serum albumin. Ann Allergy 1988;61:85-88.
26. Wilkes MM, Navickis RJ: Patient survival after human albumin administration. Ann Intern Med 2001;135:149-164.